Raymond James Projects 'Rising Momentum' At Catalent Driven By Biologics Expansion
March 21, 2018 at 14:57 PM EDT
Catalent, Inc. (NYSE: CTLT)’s plans for expansion of its biologics segment are likely to bring the stock back after weak ...